The European Union (EU) reform establishes a regulatory data and market protection period of eight years, capped at 11 years ...
The agency is approaching the new overhaul as a chance to reshape drug regulations in the European Union.
The EU pharmaceutical reform aims to improve drug accessibility, affordability, and innovation, addressing market protection and antimicrobial resistance. Co-legislators in Europe have reached a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback